Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Folia Neuropathologica|October 11, 2023
Development and initial experience of a novel classification system for patients with brain stem haemorrhageLu Li, An Ji Wang, Han Bing Zhang, et al.Microbial Pathogenesis|September 23, 2024
Natural small molecule compounds targeting Wnt signaling pathway inhibit HPV infectionTao Zhang, Ze Wang, Munawaer Muaibati, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 24, 2017
Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to RadiationMan Zou, Yanhui Li, Shu Xia, et al.Small (Weinheim an Der Bergstrasse, Germany)|November 5, 2024
Phase Transition of Wax Enabling CRISPR Diagnostics for Automatic At-Home Testing of Multiple Sexually Transmitted Infection PathogensHu Zhou, Yixuan Cai, Liang He, et al.Apoptosis : an International Journal on Programmed Cell Death|August 24, 2006
Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cellsQinglei Gao, Xiaoyuan Huang, Duozhuang Tang, et al.ACS Nano|February 26, 2026
Gravity-Driven Formation of Water-in-Wax Spheres for Efficient One-Pot CRISPR DiagnosticsYixuan Cai, Liang Zhuang, Zhijie Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2006
RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirusQinglei Gao, Jianfeng Zhou, Xiaoyuan Huang, et al.Infectious Agents and Cancer|August 8, 2024
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3Fanwei Huang, Liang He, Wei Li, et al.Current Medical Science|December 13, 2024
Genome-integrated Human Papilloma Viruses Testing: A Complement to Colposcopy-guided Biopsy for Cervical Cancer ScreeningHan Xie, Li Li, Tao Zhu, et al.Therapeutic Advances in Medical Oncology|August 19, 2022
Nab-paclitaxel plus S-1 <i>versus</i> oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)Yu-Hong Dai, Xiong-Jie Yu, Hui-Ting Xu, et al.Pageof 10